Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson’s disease mouse model

Thuy Thi Lai,Young Eun Kim,Linh Thi Nhat Nguyen,Tinh Thi Nguyen,In Hee Kwak,Franziska Richter,Yun Joong Kim,Hyeo-il Ma
DOI: https://doi.org/10.1038/s41531-024-00640-2
2024-02-02
Abstract:Abstract The accumulation of alpha-synuclein (αSyn) is widely recognized as the main pathological process in Parkinson’s disease (PD). Additionally, neuroinflammation is considered to be one of the contributing mechanisms in the development of PD. In light of this, it is hypothesized that the reactive microglia exacerbate the propagation of αSyn and neurodegeneration, while the inhibition of microglial activity may mitigate these effects. To test this hypothesis, αSyn preformed fibrils (PFF)-injected PD mouse model was employed. Co-injection of lipopolysaccharide (LPS) and PFF was performed to investigate if microglial reactivity intensified αSyn propagation and neurodegeneration. Additionally, oral administration of PLX5622, a microglial inhibitor that targets the colony-stimulating factor 1 receptor, was given for two weeks before and after PFF injection each to explore if microglial inhibition could prevent or reduce αSyn pathology. Intrastriatal co-injection of LPS and PFF resulted in increased microglial reactivity, αSyn accumulation, and neurodegeneration compared to PFF injection alone. However, treatment with PLX5622 significantly suppressed microglial reactivity, reduced αSyn pathology, and alleviated dopaminergic neuron degeneration in the PD mouse model injected with PFF. Based on these findings, it is evident that microglial reactivity plays a crucial role in the progression of αSyn pathology and neurodegeneration in PD. Furthermore, the results suggest that microglial inhibition may hold promise as a therapeutic strategy to delay the progression of αSyn pathology in PD.
neurosciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the role of microglial cell activity in the propagation of α - synuclein (αSyn) and neurodegeneration in Parkinson's disease (PD). Specifically, the study hypothesized that reactive microglial cells would exacerbate the propagation of αSyn and neurodegeneration, and that inhibiting microglial cell activity might alleviate these effects. To test this hypothesis, the researchers used a PD mouse model injected with αSyn pre - formed fibrils (PFF) and explored whether the microglial cell reaction exacerbated the propagation of αSyn and neurodegeneration by co - injecting lipopolysaccharide (LPS) and PFF. In addition, the study also explored whether microglial inhibition could prevent or reduce αSyn pathology by oral administration of PLX5622 (a microglial inhibitor targeting the colony - stimulating factor 1 receptor). ### Main research contents 1. **Establishment of PD mouse model**: - A PD mouse model was established by injecting PFF. - The reactivity of microglial cells was increased by co - injecting LPS and PFF. 2. **Observation of the effect of LPS on microglial cell reaction**: - The microglial cell reaction in mice of different groups (LPS only, PFF only, PFF + LPS, non - injected control group) was compared at different time points (14, 30, 90, 120, 150 days). - The number and activity of Iba1 - positive microglial cells were analyzed by immunohistochemistry and Western Blot. 3. **Evaluation of αSyn accumulation and neurodegeneration**: - The αSyn accumulation in mice of different groups was observed, especially the changes in the striatum and substantia nigra. - The loss of dopaminergic neurons was evaluated by stereological methods. 4. **Effect of inhibiting microglial cell activity**: - Microglial cell activity was inhibited by oral administration of PLX5622. - The differences in αSyn accumulation, neurodegeneration and motor function between the PLX5622 - treated group and the control group were compared. ### Main findings - **LPS enhances microglial cell reaction**: Co - injection of LPS and PFF significantly increased the reactivity of microglial cells, resulting in exacerbated αSyn accumulation and neurodegeneration. - **PLX5622 inhibits microglial cell reaction**: PLX5622 significantly reduced the number of Iba1 - positive microglial cells, decreased αSyn accumulation, protected dopaminergic neurons from degeneration, and improved motor dysfunction. ### Conclusion The research results indicate that microglial cell reactivity plays a crucial role in αSyn propagation and neurodegeneration, and that inhibiting microglial cell activity can alleviate these pathological processes. Therefore, microglial cells may be a potential target for the treatment of PD. However, further research is still needed to gain a deeper understanding of the detailed molecular mechanisms of microglial cells in αSyn pathology and their long - term effects.